TY  - GEN
AU  - Hing,Z A
AU  - Fung,H Y J
AU  - Ranganathan,P
AU  - Mitchell,S
AU  - El-Gamal,D
AU  - Woyach,J A
AU  - Williams,K
AU  - Goettl,V M
AU  - Smith,J
AU  - Yu,X
AU  - Meng,X
AU  - Sun,Q
AU  - Cagatay,T
AU  - Lehman,A M
AU  - Lucas,D M
AU  - Baloglu,E
AU  - Shacham,S
AU  - Kauffman,M G
AU  - Byrd,J C
AU  - Chook,Y M
AU  - Garzon,R
AU  - Lapalombella,R
TI  - Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies
SN  - 1476-5551
PY  - 2017///0814
KW  - Animals
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Hematologic Neoplasms
KW  - drug therapy
KW  - Heterografts
KW  - Humans
KW  - Karyopherins
KW  - antagonists & inhibitors
KW  - Mice
KW  - Neoplasm Invasiveness
KW  - Receptors, Cytoplasmic and Nuclear
KW  - Survival Rate
KW  - Treatment Outcome
KW  - Exportin 1 Protein
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/leu.2016.136
ER  -